发明名称 Nanoceria for the treatment of oxidative stress
摘要 A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, citric acid and ethylenediaminetetraacetic acid in a predetermined ratio, an oxidant, and water is provided along with temperature conditions to directly form, without isolation, a stable dispersion of cerium oxide nanoparticles. These biocompatible cerium oxide nanoparticles may be used to prevent and/or treat oxidative stress related diseases, such as stroke, relapse/remitting multiple sclerosis, chronic-progressive multiple sclerosis, amyotrophic lateral sclerosis, and ischemic reperfusion injury.
申请公布号 US9533007(B2) 申请公布日期 2017.01.03
申请号 US201514690781 申请日期 2015.04.20
申请人 CERION, LLC 发明人 Reed Kenneth Joseph;Costanzo Wendi Ann;Erlichman Joseph Samuel;Bell Eric Leslie
分类号 A61K9/16;A61K33/24;A61K9/10;B82Y5/00;B01J13/02 主分类号 A61K9/16
代理机构 RatnerPrestia 代理人 RatnerPrestia
主权项 1. A pharmaceutical composition for the treatment of a patient suffering from a disease associated with oxidative stress comprising a therapeutically effective amount of a dispersion of cerium-containing nanoparticles and optionally a pharmaceutically acceptable excipient, wherein the cerium-containing nanoparticles are stabilized by citric acid and ethylenediaminetetraacetic acid.
地址 Rochester NY US